Holmberg A, Bergqvist D, Siegbahn A
Department of Surgical and Medical Sciences, University Hospital Uppsala, Sweden.
Thromb Res. 1999 Oct 15;96(2):99-105. doi: 10.1016/s0049-3848(99)00072-9.
In patients with abdominal aortic aneurysms (AAA) the coagulation and fibrinolytic systems have been found to be activated preoperatively. Does the increased activity of the coagulation and fibrinolytic systems persist after AAA surgery in a long-term perspective? Prothrombin fragment 1+2 (F1+2), thrombin-antithrombin complex (TAT), tissue plasminogen activator (tPA), human plasminogen activator inhibitor type 1, and human cross-linked fibrin degradation product (D-dimer) were analysed in 18 patients after open AAA surgery (postop-AAA). The median time between surgery and blood sampling was 19 months (range, 5-37 months). Comparisons were made with both preoperative values of 23 patients with AAA (preop-AAA) as well as 20 age-matched healthy controls (AMC). F1+2, TAT, and D-dimer in preop-AAA were significantly higher compared to AMC (p<0.001). In post-op AAA patients these parameters were significantly lower compared to preop-AAA (p<0.05 for F1+2 and TAT, p<0.001 for D-dimer). However, TAT and D-dimer levels were still higher in postop-AAA than in AMC (p<0.01 for both). The activity of the coagulation and fibrinolytic systems seems to decrease after AAA surgery. However, the activity is still higher than in healthy AMC. A possible explanation may be that the thrombogenicity is lower in a vascular graft than in an aneurysmal sac but still higher than in a nonaneurysmal aorta.
在腹主动脉瘤(AAA)患者中,术前已发现凝血和纤维蛋白溶解系统被激活。从长期来看,凝血和纤维蛋白溶解系统活性增加在AAA手术后是否持续存在?对18例接受开放性AAA手术(术后AAA)的患者分析了凝血酶原片段1+2(F1+2)、凝血酶 - 抗凝血酶复合物(TAT)、组织纤溶酶原激活剂(tPA)、人纤溶酶原激活剂抑制剂1型和人交联纤维蛋白降解产物(D - 二聚体)。手术与采血之间的中位时间为19个月(范围5 - 37个月)。将结果与23例AAA患者(术前AAA)的术前值以及20例年龄匹配的健康对照者(AMC)进行比较。术前AAA患者的F1+2、TAT和D - 二聚体与AMC相比显著更高(p<0.001)。在术后AAA患者中,这些参数与术前AAA相比显著更低(F1+2和TAT为p<0.05,D - 二聚体为p<0.001)。然而,术后AAA患者的TAT和D - 二聚体水平仍高于AMC(两者均为p<0.01)。AAA手术后凝血和纤维蛋白溶解系统的活性似乎降低。然而,该活性仍高于健康的AMC。一个可能的解释可能是血管移植物的血栓形成性低于动脉瘤囊,但仍高于非动脉瘤性主动脉。